Indikationer for brug af serotoninspecifikke genoptagelseshæmmere hos børn og unge

Ugeskrift for Laeger

Volumn 160, Issue 50, 1998, Pages 7285-7290

  Thomsen, Per Hove ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; BULIMIA; CLINICAL TRIAL; DEPRESSION; DRUG INDICATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERKINESIA; INFANTILE AUTISM; MUTISM; OBSESSION; REVIEW; SEPARATION ANXIETY;

ADOLESCENT; AFFECTIVE SYMPTOMS; ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BULIMIA; CHILD; DEPRESSION; DEVELOPMENTAL DISABILITIES; HUMANS; MUTISM; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TOURETTE SYNDROME;

EID: 0032495054     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Thomsen PH. Langtidsforløbet mht. psykiatrisk sygelighed og død for børnepsykiatriske patienter: en registerbaseret undersøgelse af 546 børn. Ugeskr Læger 1998; 160: 2863-6.
2. Ebdrup M. Psykiatere dybt tienige om medicin til børn. Dagens Medicin, 12. marts 1998: 5.
3. Leonard HL, March J, Kenneth MPH, Rickler C, Allen AJ. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36: 725-36.
4. DeVane CL, Sallee FR. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: A review of published experience. J Clin Psychiatry 1996; 57: 55-66.
5. DeVane CL. Pharmacokinetics of the selective selective reuptake inhibitors. J Clin Psychiatry 1992; 53 (suppl 2): 13-20.
6. Alderman J, Wolkow R, Chung M, Johnston H. Sertraline treatment of children and adolescents with obsessive compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry. 1998; 37: 386-94.
7. Simeon J, Dinicola V, Ferguson HB, Copping W: Adolescent depression: a placebocontrolled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14: 791-5.
8. Emslie GJ, Rush J, Weinberg WA, Kowath RA, Hughes CW, Carmody T et al A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 1997; 54: 1031-7.
9. Keller MB, Ryan ND, Birmaher B, Klein RG, Strober M, Wagner KD et al. Paroxetine and imipramine in the treatment of adolescent depression. New reseach presentation (NR206) at The American Psychiatric Association Annual Meeting, Toronto, Canada, 1998. Washington: American Psychiatr Association, 1998: 123.
10. McConville BJ, Minnery KL, Sorter MT, West SA, Friedman LM, Christian K. An open study of the effects of sertraline on adolescent major depression. J Child Adolesc Psychopharmacol 1996; 6: 41-51.
11. Tierney E, Joshi PT, Llinas JF, Rosenberg LA, Riddle MA. Sertraline for major depression in children and adolescents: Preliminary clinical experience J Child Adolesc Psychopharmacol 1995; 5: 13-27.
12. Boulos C, Kutcher, Gardner D. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adolesc Psychopharmacol 1992; 2: 103-11.
13. Jain U, Birmaher B, Carcia M, Al-Shabbont M, Ryan N. Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 1992; 2: 259-65.
14. Apter A, Ratzoni G, King RA, Weizmann A, Iancu I, Binders M et al. Fluvoxamine open-label treatment of adolescent inpatients with obsessive compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry 1994; 33: 342-8.
15. Thomsen PH. Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature. Eur Child Adolesc Psychiatry 1996; 5: 55-66.
16. Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies J Clin Psychiatry 1997; 58 (suppl 12): 18-22.
17. Riddle MA, Hardin MT, Scahill L, King RA, Woolston JL. Double-blind trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1990; 29: 45-8.
18. Geller DA, Biederman J, Reed ED. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1995; 34: 36-44.
19. Thomsen PH. Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from and open trial of 23 cases. J Child Adolesc Psychopharmacol 1997; 7. 157-66
20. Goodmann WK, Lawrence PH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al. The Yale-Brown Obsessive-Compulsive Scale. I. Development, use and reliability. Arch Gen Psychiatry 1989; 46. 1006-11.
21. Black B, Uhde TW. Fluoxetine treatment of elective mutism; a double blind placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994: 33; 1000-6.
22. Black B, Uhde TW. Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 1992. 31: 1090-4.
23. Dummit ES, Klein RG Tancer NK, Asche B, Martin J. Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 1996, 35: 615-21.
24. Kurlan R, Como PG, Deeley C. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropharmacol 1993, 16: 167-72.
25. Birmaher B, Waterman GS, Ryan N. Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1994; 33: 993-9.
26. Barrickman L, Noyes R, Kuperman S. Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 1991, 30: 762-7.
27. Gammon GD, Brown TE: Fluoxetine and methylphemidat in combination for treatment of attention deficit disorder and comorbid depressive disorede. J Child Adolesc Psychopharmacol 1993; 3: 1-10.
28. Cook EH, Rowlett R, Jaselskis C, Leventhal BL. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 1992; 31: 739-45.
29. Kaye WH, Weltzin TE, Hsu LKG, Bulik CM, McConaha C. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991; 52: 464-71.
30. Trygstad O. Drugs in the treatment of bulimia nervosa. Acta Psychiatr Scand Suppl 1990; 361: 34-7.